Development and validation of a new HPLC method for the determination of gabapentin

International Journal of Biomedical Science

Volumn 5, Issue 1, 2009, Pages 63-69

  Gujral, Rajinder Singh ^a   Haque, Sk Manirul ^a  

^a Vardhman Chemtech Ltd   (India)

Author keywords

Gabapentin; High performance liquid chromatography; Potassium iodate; Potassium iodide

Indexed keywords

GABAPENTIN; POTASSIUM IODATE; POTASSIUM IODIDE;

ACCURACY; ARTICLE; CHEMICAL REACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SPECIFICITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PROCESS OPTIMIZATION; REPRODUCIBILITY; VALIDATION PROCESS;

EID: 77953365457     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. N. T. Mathew, A. Rapoport, J. Saper, L. Magnus, J. Klapper, N. Ramadan, B. Stacey, S. Tepper. Headache. 2001; 41, 119-128.
2. M. M. Backonja. J. Serra. Pain Med. 2004; 5: S28-47.
3. J. Choudhuri, N. Sarvananthan, I. Gottlob. Eye. 2006; 21:1194.
4. G. Chouinard. J. Psychiatry Neurosci. 2006; 31:168-176.
5. Frye, A. Mark. J. Clinical Psychopharmacology. 2000; 20:607-614.
6. Mack, Alicia. J. Managed Care Pharmacy. 2003; 9:559-568.
7. P. N. Patsalos. Seizure. 1994; 3:163-170.
8. M. J. McLean, Gabapentin: chemistry, absorption, distribution and excretion. In: R. Levy, R. Mattson, B. Meldrum, eds. Antiepileptic Drugs, New York, Raven Press Ltd. 1995; 843-849.
9. M. M. Kushnir, J. Crosset, P. I. Brown, F. M. Urry. J. Anal. Toxicol. 1999; 23:1-6.
10. C. E. Wolf, J. J. Saady, A. Poklis, J. Anal. Toxicol. 1996; 20:498-501.
11. D. C. R. Borrey, K. O. Godderis, V. I. L. Engerlrelst, D. R. Bernard, M. R. Langlois, Clin. Chim. Act. 2005; 354:147-151.
12. T. M. Chen, J. J. Contario, J. Chromatogr. 1984; 314:495-498.
13. T. M. Chen, R. R. Fike, Chromatography. 1990; 11:4-5.
14. S. George, L. Gill, R.A. Braithwaite, Clin. Biochem. 2000; 37:338-342.
15. Z. Zhu, L. Neirinck, J. Chromatogr. 2002; 779:307-312.
16. S. M. Cetin, S. Atmaca, J. Chromatogr. 2004; 1031:237-242.
17. T. A. C. Vermeij, P. M. Edelborek, J. Chromatogr. B. 2004; 810:297-303.
18. L. L. Garcia, Z. K. Shihabi, K. Oles, J. Chromatogr. B. 1995; 669:157-162.
19. F. M. Lin, H. S. Lin, H. S. Kou, S. M. Wu, S. H. Chen, H. L. Wu, Anal. Chim. Act. 2004; 523:9-14.
20. J. Al - Zehouri, S. Al - Madi, F. Belal, Arzeneim Forsch. 2001; 51:97-103.
21. N. Olgun, S. Erturk, S. Atmaca, J. Pharm. Biomed. Anal. 2002; 29:1-5.
22. F. Belal, H. Abdine, A. Al - Majed, N. Y. Khalil, J. Pharm. Biomed. Anal. 2002; 27: 253-260.
23. "The United states Pharmacopoeia, 30th revision, Asian Edition, United states pharmacopoeial convention, Inc., Twin brook Parkway, Rockville, MD. 2007: 2200.
24. F. Feigl. Spot tests in organic analysis. Chapter 3: Preliminary (Exploratory tests), 6th ed., Elsevier publishing company, Amsterdam. 117-118.
25. International Conference on Harmonization of technical requirements for the registration of pharmaceuticals for Human Use (ICH) Q2A. Validation of Analytical Methods (Definitions and Terminology) (October 1994).
26. ICH: Q2B Analytical Validation Methodology (November 1996).
27. A. Gupta, A. B. Ciavarella, V. A. Sayeed, M. A. Khan, P. J. Faustino, J. Pharm. Biomed. Anal. 2008; 46:181-186.